February 2020
Oseltamivir on the Move, but Where Should It Go?
February 24, 2020
Article
Editor-in-Chief Letter
Just as influenza season started ramping up in the Northern Hemisphere, news hit the wire that Sanofi had secured over-the-counter rights for oseltamivir (Tamiflu).
Diagnostic Stewardship: Beyond Managing Bloodstream Infections
February 21, 2020
Article
Stewardship & Prevention
Diagnostic stewardship is a novel concept related to modifying the process of ordering, testing, and reporting with the goal of decreasing unnecessary testing and treatment, working upstream and synergistically with antimicrobial stewardship principles.
Never Ignore a New Rash in a Patient With AIDS
February 20, 2020
Article
Case Study
A case of Kaposi sarcoma with immune reconstitution inflammatory syndrome.
Bacteriophage-Antibiotic Combinations: A Promising Alternative for Refractory Infections?
February 19, 2020
Article
Multidrug-Resistant Infections
Despite the initial abandonment of bacteriophages in most areas of the world, the era of antibiotic resistance has led to a resurgence of phage therapy in clinical practice.
Five Ways ID Clinicians Can Take On Antibiotic Resistance: Highlights From the CDC's Latest Report
February 18, 2020
Article
Emerging & Re-Emerging Infections
A death from an antibiotic-resistant infection occurs about every 15 minutes in the United States. The CDC’s 2019 threat report dives into national infection estimates and actions we can take to combat this threat.
Addressing Weight Gain That Follows Life-Saving Antiretroviral Therapy
February 17, 2020
Article
HIV / AIDS
Clinicians must identify when additional pounds cross the line of diminishing return.
Transitioning From Adequate to Optimal Therapy in Staphylococcus aureus Bacteremia
February 14, 2020
Article
Acute Infections
Therapy options have increased in recent decades, yet there is a lack of guidance.
Imipenem-Cilastatin-Relebactam: Imipenem Is Rele Back Again
February 13, 2020
Article
News and Breakthroughs
The US Food and Drug Administration approved imipenem-cilastatin-relebactam to treat complicated intra-abdominal infections and complicated urinary tract infections in adults with limited treatment options.
Consider the MIC: Treating Respiratory Infections Caused by Pseudomonas aeruginosa With Ceftolozane/Tazobactam
February 12, 2020
Article
In the Literature
When using ceftolozane/ tazobactam to treat patients with P aeruginosa respiratory tract infections, the use of extended or continuous antibiotic infusion and/or combination therapy with other active antibiotic agents should be considered, particularly if targeting higher MIC values.
The Early Bird Gets to Stay Home: Early OPAT Follow-Up Reduces 30-Day Readmissions
February 11, 2020
Article
In the Literature
Readmission rates for patients receiving OPAT are reported to be as high as 20%, mostly due to catheter-related problems, adverse drug reactions, or worsening of the primary infection.
Clinical Characteristics of the First 2019-nCoV Cases in Wuhan, China
January 24, 2020
Article
Medical World News
A new article published in The Lancet features information on epidemiology, laboratory, and radiology elements of the first 41 cases of the novel coronavirus confirmed in Wuhan, China.
Few US Child Care Centers Require Flu Vaccine
January 02, 2020
Article
Medical World News
Despite children’s higher risk of complications from influenza, few US child care centers report influenza vaccine requirements for children and/or adult care workers.
CDC Details First Shewanella haliotis Case in the Americas
December 24, 2019
Article
Medical World News
CDC has detailed the first reported case of Shewanella haliotis in the region of the Americas, describing a 2018 case in Flushing, New York.
FDA Declines to Approve Cabotegravir/Rilpivirine
December 21, 2019
Article
Medical World News
The FDA has issused a complete response letter to ViiV Healthcare for cabotegravir/rilpivirine.
Ebola Vaccine Approved by FDA
December 20, 2019
Article
Medical World News
Ervebo has been approved for the prevention of Ebola virus disease, caused by Zaire ebolavirus in individuals 18 years of age and older.
Evaluating Meropenem and Piperacillin/Tazobactam for Empiric Sepsis Treatment
December 18, 2019
Article
Meeting Coverage
Piperacillin/tazobactam and meropenem are both accepted as options for empiric antibiotic therapy due to their broad-spectrum activity
Can Improving Penicillin Allergy Documentation Cut Costs?
December 18, 2019
Article
Meeting Coverage
A team of pharmacists at Baptist Hospital reported that improving penicillin allergy documentation and increasing the use of β-lactams had potential cost savings of $21,468 over a 3-month period.
"Don't Call Me the Berlin Patient, Call Me Timothy Ray Brown"
November 09, 2019
Article
Meeting Coverage
“My story is important only because it proves that HIV can be cured. And if something has happened, once in medical science, it can happen again,” Brown told Contagion®.
Speed of Processing Training Resulted in Significant Improvements for Individuals With HAND
November 08, 2019
Article
Meeting Coverage
There is a vast unmet need for non-pharmacological treatment strategies to protect and improve cognitive function in the approximately 50% of adults living with HIV who experience HIV-associated neurocognitive disorder.
IDWeek 2019 News Network: Assessing Challenges to Treating CABP
October 24, 2019
Video
Peer Exchange
Thomas Lodise, PharmD, PhD, provides an overview of options for treating community-acquired bacterial pneumonia and highlights the challenges of the infection.